Explore News By Topic
08/10/2017
Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs
Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More
08/04/2017
Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment
Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More
08/02/2017
Comprehensive sequencing program shows promise of precision medicine for advanced cancer
ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More
07/10/2017
Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients
SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating the delivery of life-extending and life-saving therapies for men living with prostate cancer. The YI Awards provide three years of... Read More
06/19/2017
New three-in-one blood test opens door to precision medicine for prostate cancer
Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance LONDON, June 18, 2017 - Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate... Read More
06/03/2017
Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival
ASCO Perspective “For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,” said Sumanta Kumar Pal, MD, ASCO Expert. “This is good news because using abiraterone could help many people live longer with fairly few additional side... Read More
06/01/2017
Prostate Cancer Foundation and Major League Baseball Launch Annual Home Run Challenge to Defeat Prostate Cancer
LOS ANGELES, June 1, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are launching the annual Home Run Challenge on June 1, and running through Father's Day, June 18, in all 30 MLB ballparks throughout the United States and Canada. For the first time, all MLB... Read More
05/17/2017
Many vs Cancer, the First Major Global Crowdfunding Initiative to Defeat Prostate Cancer, Launches Today
LOS ANGELES, May 17, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the launch of Many vs Cancer (MvC), its first global fundraising initiative that is harnessing the collective power of those touched by prostate cancer with the scientists working to defeat it. MvC aims to empower patients,... Read More
05/17/2017
Study finds genetic difference in prostate cancer in African-Americans
Dana-Farber Cancer Institute News Release May 17,2017 The genomic discovery may partly explain why prostate cancer is more aggressive in black men Scientists say more blacks and other under-represented groups should be included in genomic studies to enable precision medicine BOSTON –– A new genomic study has identified prostate cancer... Read More
05/11/2017
Scientists Identify Biomarkers to Guide Hormone Therapy for Prostate Cancer
University of California San Francisco News Release May 11, 2017 A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy, according to a study led by scientists at UC San Francisco and the University of Michigan.... Read More